TL;DR: Spect is a Y Combinator Summer 2017 startup Value-based retinal screening in primary care to prevent blindness. , currently inactive with a team of 7.
Value-based retinal screening in primary care to prevent blindness.
Last verified:
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
Built by LemStudio
Yes. Spect was funded by Y Combinator in the Summer 2017 batch. Value-based retinal screening in primary care to prevent blindness.
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fun…
Spect was part of Y Combinator's Summer 2017 batch.
Spect has a team of 7 people according to Y Combinator's directory.
Spect is currently listed as Inactive with a team of 7 in Y Combinator's directory.
Loading interactive view…